Stock Appreciation Right
A Stock Appreciation Right (SAR) is an employee compensation award that entitles the holder to receive the increase in a company's stock price above a set base price over a specified period, paid in cash or shares, without requiring the employee to purchase shares or commit capital upfront.
Stock Appreciation Rights function economically like stock options — the employee profits when the stock price rises above the grant price — but differ in important structural ways. With a stock option, the employee must pay the exercise price to purchase shares, which requires capital and often results in the employee immediately selling shares to cover the cost (a same-day sale or net exercise). With a SAR, the employee simply receives the value of the appreciation: if the stock was at $50 at grant and is at $80 at exercise, the employee receives $30 per SAR in cash or equivalent shares, with no capital outlay required.
SARs can be settled in cash, stock, or a combination. Cash-settled SARs are straightforward — the employee receives a cash payment equal to the spread and pays ordinary income taxes in the year of exercise. Stock-settled SARs deliver shares with a value equal to the spread; the employee still owes ordinary income tax on the value received, and the company withholds taxes by delivering fewer shares than the gross appreciation value would indicate.
Tandem SARs are granted alongside stock options, allowing the employee to choose which instrument to exercise (though exercising one cancels the other). Stand-alone SARs exist independently. SARs are common in private companies that want to provide stock-price-linked upside to employees without issuing actual equity (which would require securities compliance, shareholder dilution, and complex cap table management), and in companies whose shares are traded on foreign exchanges where delivering shares to domestic employees would be administratively burdensome.
From a tax perspective, SARs receive ordinary income treatment at exercise — the spread is W-2 compensation subject to FICA taxes, federal and state income taxes, just like a non-qualified stock option. There is no long-term capital gains treatment at exercise. If stock is received and held post-exercise, subsequent appreciation beyond the exercise-date value can qualify for long-term capital gains treatment after a one-year holding period.
Vesting schedules for SARs typically mirror those of stock option grants — cliff vesting over 1–4 years, or graded vesting releasing portions annually — and SARs generally expire 7–10 years from grant if not exercised. Employees should track grant prices, vesting dates, and expiration dates carefully, as unexercised SARs that expire worthless represent permanent loss of potential compensation.